Investors forum

Hosted by Johnson & Johnson Innovation

Young companies active in the life sciences industry, pitch your company and/or innovations at the Dutch Life Sciences conference. Increase your visibility, earn PR and connect to collaboration partners and investors.

The Investors forum is an exciting opportunity for young life sciences companies that have not reach the series A financing stage and looking for equity capital and/or partnerships. The forum offers excellent opportunities for presenting your company to Venture Capitalists, corporate- and regional investment funds and discuss your business strategy.

Participate in the Investors Forum and grab your chance to meet with interesting partners, initiate strategic alliances or tap into the international financing networks.

Participating investors 
The Investors Forum enables you to evaluate new investment opportunities and to meet with the management of the most promising life sciences companies, start-ups as well as established ventures. After the forum there will be ample opportunity to further discuss future collaborations in one-on-one meetings.

Investors 2023 present:

• Curie Capital
• EQT Life Sciences
• FIRST fund at BioGeneration Ventures
• FORTY51 Ventures
• Free Bee International
• Invest-NL
• LEH Libertatis Ergo Holding BV
• LIOF
• Mibiton
• Nextgen Ventures
• Oost NL
• ROM Utrecht Region
• Starfish Innovations
• Thuja Capital
• Utrecht Health Seed Fund

Pitching companies
Prior to the event, companies will be invited for a test presentation. The Investors Forum committee will provide feedback and give advice.

The winner of the Investors Forum will be awarded the ´Investors Forum prize´, a partnering ticket with a total value of EUR 2,500 and will be allowed to repeat the winning pitch in the plenary programme. 

All selected pitching parties will be invited to the VIP speakers- and partners dinner the evening before the conference.

Upon registration you will be given further details.

Selected pitching companies 2023: 

• Cantoni Therapeutics > Therapeutic
• Doser > Medical device
• ExCulture > Bioprocessing heparin-like compounds
• Fenix Therapeutics > Therapeutics
• GeneScape > Data analytics
• Incircular > Enabling technology
• INITIO CELL > Organ-on-chip device
• Korecyte Bio > Organ-on-chip device
• Paramedir > Medical device
• Predica Diagnostics BV > Diagnostics
• SurvivX B.V. > Therapeutic
• XS Innovations > Medical device

General information and registration 
During the conference the forum will be held in two sessions:

• Part 1 - breakfast session (08:00 - 09:00)
• Part 2 - lunch session (13:00 - 14:00)

This will enable participants to attend the complete programme of the conference as well. Participation in the Investors Forum involves no additional costs. Conference registration is all that is required. If you are interested in participating in the Investors Forum, please contact Miranda de Regt at miranda.de.regt@dutchlifesciences.com.

You will be contacted for further details upon registration. Participation will be reviewed by the programme committee. The candidates have to perform a test pitch which will be part of the selection procedure. Your participation in the Investors Forum will be definite after receiving your personal invitation. 

The Investors Forum may be sold out.

Deadline to apply: 18 November, 2024